Matthias U. Kassack

7.0k citations

153 papers · 5.5k indexed · h-index 48

Co-authors: Alexandra Hamacher Peter Nickel Finn K. Hansen Thomas Kurz Michael D. Wiese H. Mueller Heiko Ullmann Niels Eckstein
Topics: Histone Deacetylase Inhibitors Research (34 papers)Adenosine and Purinergic Signaling (23 papers)Receptor Mechanisms and Signaling (21 papers)
Cited by: Physiology Pharmacology Geriatrics and Gerontology
Journals: Journal of Biological Chemistry Angewandte Chemie International Edition The Journal of Immunology
Partner nations: Germany United States China

In The Last Decade

Matthias U. Kassack

149 papers receiving 5.4k citations

Peers

Countries citing papers authored by Matthias U. Kassack

Since Specialization

Citations

This map shows the geographic impact of Matthias U. Kassack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias U. Kassack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias U. Kassack more than expected).

Fields of papers citing papers by Matthias U. Kassack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias U. Kassack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias U. Kassack. The network helps show where Matthias U. Kassack may publish in the future.

Co-authorship network of co-authors of Matthias U. Kassack

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias U. Kassack. A scholar is included among the top collaborators of Matthias U. Kassack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias U. Kassack. Matthias U. Kassack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers DS-103 as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties 2025 ·Journal of Medicinal Chemistry ·(unknown),(unknown),P. R. Watson,Jingyu Li,(unknown),(unknown),Laís Pessanha de Carvalho,Jana Klose,(unknown),Alexandra Hamacher,Linda Schäker‐Hübner,(unknown),Jana Held,David W. Christianson,Matthias U. Kassack,Finn K. Hansen	5
2	Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer 2024 ·Cancers ·(unknown),(unknown),Alexandra Hamacher,(unknown),Linda Schäker‐Hübner,Finn K. Hansen,Matthias U. Kassack	1
3	YAK577 Attenuates Cardiac Remodeling and Fibrosis in Isoproterenol-Infused Heart Failure Mice by Downregulating MMP12 2024 ·Korean Circulation Journal ·(unknown),Hae Jin Kee,(unknown),(unknown),Fabian Fischer,Matthias U. Kassack,Thomas Kurz,(unknown),Seung‐Jung Kee,Young Joon Hong,Myung Ho Jeong	4
4	Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas 2022 ·Oral Oncology ·(unknown),(unknown),(unknown),Michèle J. Hoffmann,(unknown),Alexandra Hamacher,Matthias U. Kassack,Constanze Wiek,Kathrin Scheckenbach,Helmut Hanenberg	15
5	Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1 2020 ·Cancers ·(unknown),Alexandra Hamacher,Patrick Petzsch,Karl Köhrer,Günter Niegisch,Michèle J. Hoffmann,Wolfgang A. Schulz,Matthias U. Kassack	25
6	In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi) 2020 ·International Journal of Molecular Sciences ·Annabelle Friedrich,(unknown),(unknown),(unknown),Matthias U. Kassack,Wolfgang A. Schulz,Wynand P. Roos,Finn K. Hansen,(unknown),Thomas Kurz,Gerhard Fritz	9
7	Distinct influence of the anthracycline derivative doxorubicin on the differentiation efficacy of mESC-derived endothelial progenitor cells 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Sarah Jahn,(unknown),Matthias U. Kassack,(unknown),Andreas S. Reichert,Gerhard Fritz	9
8	Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance 2019 ·Bioorganic & Medicinal Chemistry ·(unknown),Alexandra Hamacher,(unknown),(unknown),(unknown),(unknown),Matthias U. Kassack,Thomas Kurz	10
9	Allosteric activation of human α-thrombin through exosite 2 by suramin analogs 2012 ·Archives of Biochemistry and Biophysics ·(unknown),(unknown),(unknown),Robson Q. Monteiro,Matthias U. Kassack,Luís Maurício T. R. Lima	2
10	Prenylation at the indole ring leads to a significant increase of cytotoxicity of tryptophan-containing cyclic dipeptides 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Alexandra Hamacher,Xia Yu,Matthias U. Kassack,Shu‐Ming Li	41
11	[(C₃H₄N₂)₂Au]Cl—a bis protic gold(i)-NHC 2010 ·Dalton Transactions ·P.C. Kunz,(unknown),(unknown),Matthias U. Kassack,Bernhard Spingler	52
12	Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells 2009 ·Cancer Research ·Niels Eckstein,Kati Servan,Barbara Hildebrandt,(unknown),Georg von Jonquières,(unknown),(unknown),Alexandra Hamacher,Matthias U. Kassack,Jan Budczies,Manfred Beier,Manfred Dietel,Brigitte Royer‐Pokora,Carsten Denkert,Hans‐Dieter Royer	134
13	Acquired cisplatin resistance in the head–neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1 2008 ·International Journal of Cancer ·(unknown),Niels Eckstein,Alexandra Hamacher,Kati Servan,Georg von Jonquières,Hermann Lage,Balázs Győrffy,Hans Dieter Royer,Matthias U. Kassack	66
14	Inhibition of Neutrophil Apoptosis by ATP Is Mediated by the P2Y11 Receptor 2007 ·The Journal of Immunology ·(unknown),Leanne Stokes,Lynne R. Prince,Helen M. Marriott,Sabine Meis,Matthias U. Kassack,Colin D. Bingle,Ian Sabroe,Annmarie Surprenant,Moira K. B. Whyte	108
15	NAADP+ is an agonist of the human P2Y11 purinergic receptor 2007 ·Cell Calcium ·Iliana Moreschi,Santina Bruzzone,(unknown),Cesare Usai,Lucrezia Guida,Robert A. Nicholas,Matthias U. Kassack,Elena Zocchi,Antonio De Flora	43
16	Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells 2006 ·Biochemical Pharmacology ·Jochen Zisowsky,(unknown),(unknown),Krishna Devarakonda,Matthias U. Kassack,Maja Osmak,Ulrich Jaehde	124
17	Extracellular NAD⁺Is an Agonist of the Human P2Y₁₁Purinergic Receptor in Human Granulocytes 2006 ·Journal of Biological Chemistry ·Iliana Moreschi,Santina Bruzzone,Robert A. Nicholas,Floriana Fruscione,Laura Sturla,Federica Benvenuto,Cesare Usai,Sabine Meis,Matthias U. Kassack,Elena Zocchi,Antonio De Flora	114
18	Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis 2006 ·BMC Pharmacology ·Alexandra Hamacher,(unknown),Michael Wiese,Barbara Hoefgen,Jochen Lehmann,Matthias U. Kassack	16
19	Use‐dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676 2005 ·British Journal of Pharmacology ·(unknown),Matthias U. Kassack,Heiko Ullmann,(unknown),M. Hohenegger	10
20	Functional Screening of G Protein–Coupled Receptors by Measuring Intracellular Calcium with a Fluorescence Microplate Reader 2002 ·SLAS DISCOVERY ·Matthias U. Kassack,(unknown),Jochen Lehmann,Niels Eckstein,J. Mark Quillan,Wolfgang Sadée	65

About Matthias U. Kassack

Matthias U. Kassack is a scholar working on Physiology, Pharmacology and Toxicology, having authored 153 papers that have together received 5.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (34 papers), Adenosine and Purinergic Signaling (23 papers) and Receptor Mechanisms and Signaling (21 papers). The work is most often cited by research in Physiology (1.0k citations), Pharmacology (809 citations) and Geriatrics and Gerontology (172 citations). Matthias U. Kassack has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Alexandra Hamacher, Peter Nickel, Finn K. Hansen, Thomas Kurz, Michael D. Wiese, H. Mueller, Heiko Ullmann, Niels Eckstein, Peter Proksch and Sabine Meis. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact